País: Taiwán
Idioma: chino
Fuente: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Remdesivir
香港商吉立亞醫藥有限公司台灣分公司 臺北市信義區松仁路32號10樓之1、36號10樓之1 (54376860)
J05AB
注射液劑
主成分 (per preparation unit/vial) ; Remdesivir (0800001000) This product contains 6% overage of the labeled amount, and the amount of each ingredient correspond to the actual filled amount is shown in the above.MG
盒裝
製 劑
限由醫師使用
GLIEAD SCIENCES, INC. 1800 WHEELER AVENUE LA VERNE, CA 91750 USA US
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
重度新型冠狀病毒(SARS-CoV-2)感染症
註銷日期: 2021/06/02; 註銷理由: 自請註銷; 有效日期: 2025/06/02; 英文品名: Veklury Solution for Injection 100 mg/ 20ml
已註銷
2020-06-02
2-8 30 24 36 1. 1.1 remdesivir 8.29.211.1.1 1.2 remdesivir 8.39.311.1.2 1.3 3.5 < 40 100 / 2. 2.1 VEKLURY 3. 3.1 100 / 20 100 / Remdesivir 1 100 / 20 100 2 sulfobutylether- -cyclodextrin sodium 6360 pH sulfobutylether- -cyclodextrin sodium 3146 pH 1 106 / 21.2105 2 3.2 100 / 20 100 / pH 3.0-4.0 3.0-4.0 1 2 1.2 1.3 JP 1.1 JP 1 19 2 100 200 remdesivir 250 4. SARS-CoV-2 ≤ 94% ECMO 5. 5.1 VEKLURY SARS-CoV-2 17.1.1 5.2 VEKLURY room air ≤ 94%ECMO SARS-CoV-2 17.1.1 6. 1 ≥ 40 1 IV remdesivir 200 2 IV remdesivir 100 2 3.5 < 40 1 IV remdesivir 5 / 2 IV remdesivir 2.5 / 3 10 4 5 10 7. 7.1 30 120 8.414.1 14.2 7.2 VEKLURY 10 5 10 7.3 3.5 < 40 VEKLURY 7.4 9.7 16.6.1 8. 8.1 VEKLURY VEKLURY AST ALT ALP 酶 8.2 remdesivir 1.19.2 11.1.1 8.3 remdesivir 1.29.3 11.1.2 8.4 7.111.1.3 9. 9.2 sulfobutylether- -cyclodextrin sodium remdesivir 1.1 8.2 11.1.115.2 16.6.2 9.2.1 eGFR < 30 / / 1.73 2 7 28 ≥ 1 mg/dL remdesivir 9.717.1.1 9.3 9.3.1 ALT ≥ 5 17.1 9.3.2 ALT < 5 remdesivir 1.2 8.3 11.1.216.6.3 17.1 9.5 remdesivir - IV 20 / remdesivir 苷 AUC 4 - remdesivir 10 / 苷 AUC 1.3 9.6 remdesivir remdesivir r emdesivir 9.7 remdesivir sulfobutylether- -cyclodextrin sodium < 2 9.2 7.4 16.6.1 9.8 remdesivir 10. remdesivir - 16.7.1 16.7.2 10.2 Hydroxychloroquine Sulfate Chloroquine remdesivir chloroquine remdesivir 11. VEKLURY 17.1 remdesivir 11.1 11.1.1 1.18.2 9.2 11.1.2 1.28.3 9.3 ALT ALP INR 11.1.3 8.4 14. 14.114.1.1 20 25 20 25 12 14.1.2 14.1.3 ≥ 40 1remdesivir 200 2 20 40 250 2 remdesivir 100 1 20 250 14.1.4 20 14.1.5 20 25 > 4 2 8 > 24 Leer el documento completo14.1.6 19 30 2 3 5 / 14.1.7 14.1.8 remdesivir 20 25 4 2 8 24 14.1.9 ≥ 40 1remdesivir 200 2 20 40 100 250 2remdesivir 100 1 20 100 250 3.5 < 40 1 2 14.1.10 20 14.1.11 20 25 > 4 2 8 > 24 1. 1 3.5 < 40 1 0.9% 3.5 17.5 1 3.5 25 4 20 1 4 5 25 1 5 7.5 37.5 1 7.5 50 10 50 1 10 15 75 1 15 100 20 100 1 20 25 125 a 2 25 20+5 30 150 a 2 30 20+10 35 175 a 2 35 20+15 250 2. 2 3.5 < 40 < 40 0.9% 3.5 8.8 1 1.8 25 4 10 1 2 5 12.5 1 2.5 7.5 18.8 1 3.8 50 10 25 1 5 15 37.5 1 7.5 20 50 1